Medicare Enrolled
Dr. Ryan Flynn, M.D.
Urology Physician · Cincinnati, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Flynn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flynn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Flynn
Dr. Ryan Flynn is an urology physician in Cincinnati, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Flynn performed 5,256 Medicare services across 1,962 unique beneficiaries.
Between the years covered by Open Payments, Dr. Flynn received a total of $14,877 from 60 pharmaceutical and/or device companies across 713 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Flynn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 6% volume in OH
$14,877 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,256
Medicare services
Top 6% in OH for urology physician
1,962
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~328 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,551 | $2 | $9 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
668 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
610 | $88 | $249 |
| PSA test (prostate cancer screening) | 154 | $18 | $71 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
150 | $8 | $32 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
124 | $46 | $206 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
105 | $8 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $110 | $394 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
63 | $40 | $2,513 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
59 | $65 | $468 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
57 | $8 | $50 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $58 | $626 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $59 | $193 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
44 | $8 | $39 |
| Simple change of bladder tube | 42 | $69 | $266 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $24 | $312 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
41 | $5 | $37 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
36 | $18 | $85 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
36 | $4 | $29 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
36 | $20 | $51 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
34 | $17 | $73 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
33 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
33 | $8 | $105 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $103 | $318 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $139 | $702 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
17 | $5 | $247 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
15 | $159 | $3,278 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
15 | $14 | $152 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
13 | $27 | $557 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $361 | $2,665 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $94 | $543 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $128 | $316 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $39 | $112 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $50 | $351 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
3.3% medium
96.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,877
Total received (2018-2024)
Avg $2,125/year across 7 years
Top 11% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
713
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,545 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$232 (1.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,727
2023
$2,890
2022
$2,798
2021
$2,057
2020
$996
2019
$2,188
2018
$1,221
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$342
ABBVIE INC.
$284
Sumitomo Pharma America, Inc.
$221
Medtronic, Inc.
$177
UROGEN PHARMA, INC.
$176
Astellas Pharma US Inc
$164
Teleflex LLC
$150
Janssen Biotech, Inc.
$140
Calyxo, Inc.
$138
SRS Medical Systems, Inc.
$135
Merck Sharp & Dohme LLC
$112
PROGENICS PHARMACEUTICALS, INC.
$105
Novartis Pharmaceuticals Corporation
$85
COLOPLAST CORP
$83
Axonics, Inc.
$66
PFIZER INC.
$65
Bayer Healthcare Pharmaceuticals Inc.
$46
ACCORD HEALTHCARE, INC.
$42
Ferring Pharmaceuticals Inc.
$39
Tolmar, Inc.
$37
IMMUNITYBIO, INC.
$36
Olympus America Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
BIOTISSUE HOLDINGS INC.
$18
KARL STORZ Endoscopy-America
$15
Top 3 companies account for 31.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,673
Teleflex LLC
$1,289
Janssen Biotech, Inc.
$1,105
Dendreon Pharmaceuticals LLC
$1,004
EMD Serono, Inc.
$812
Axonics, Inc.
$642
Coloplast Corp
$588
UroGen Pharma, Inc.
$562
ABBVIE INC.
$516
PFIZER INC.
$446
Merck Sharp & Dohme LLC
$388
Bayer HealthCare Pharmaceuticals Inc.
$387
Sumitomo Pharma America, Inc.
$366
Medtronic, Inc.
$362
UROGEN PHARMA, INC.
$360
NeoTract Inc.
$337
Myovant Sciences Inc.
$328
COLOPLAST CORP
$242
SRS Medical Systems, Inc.
$241
Olympus America Inc.
$239
TOLMAR Pharmaceuticals, Inc.
$219
Axonics Modulation Technologies, Inc.
$184
ACCORD HEALTHCARE, INC.
$169
Boston Scientific Corporation
$166
Ferring Pharmaceuticals Inc.
$164
Bayer Healthcare Pharmaceuticals Inc.
$159
Calyxo, Inc.
$155
Blue Earth Diagnostics Limited
$151
Antares Pharma, Inc.
$131
Novartis Pharmaceuticals Corporation
$114
PROGENICS PHARMACEUTICALS, INC.
$105
Endo Pharmaceuticals Inc.
$101
COMSORT, Inc
$100
AstraZeneca Pharmaceuticals LP
$87
Sun Pharmaceutical Industries Inc.
$85
Tolmar, Inc.
$81
Merck Sharp & Dohme Corporation
$81
Clarus Therapeutics Inc.
$79
AbbVie, Inc.
$63
UROVANT SCIENCES INC
$58
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
Progenics Pharmaceuticals, Inc.
$51
Amgen Inc.
$45
Mission Pharmacal Company
$37
IMMUNITYBIO, INC.
$36
PROCEPT BioRobotics Corporation
$33
Allergan, Inc.
$29
DENTSPLY IH Inc.
$29
ConvaTec Inc.
$27
CONMED Corporation
$25
Baxter Healthcare
$24
Accord Healthcare, Inc.
$18
BIOTISSUE HOLDINGS INC.
$18
BAXTER HEALTHCARE
$18
Hollister Incorporated
$17
GENZYME CORPORATION
$16
Foundation Medicine, Inc.
$16
KARL STORZ Endoscopy-America
$15
AbbVie Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$12
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · Axonics r-SNM System · Axumin · BAVENCIO · BOTOX · Bulkamid · CAMCEVI · CEREC · CONTINENCE CARE · CT3000 Pro Base Unit · CVAC · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLOSEAL · FOUNDATIONONE · GEMTESA · GENTLECATH · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LITHOVUE EMPOWER · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PROVENGE · PYLARIFY · Peristeen · Prolia · SPEEDICATH · SUTENT · SpeediCath · TOVIAZ · UROLIFT · Uribel · UroCuff · UroLift · UroLift System · Urocit-K · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · isiris aStent Removal Device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
84
Per 100K population
10.1
County median income
$70,816
Nearest hospital
MERCY HEALTH - WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Flynn is a clinical cardiology specialist, with above-average Medicare volume (top 6% in OH), with low-engagement industry engagement in the top 11% of OH peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Flynn experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Flynn performed 2,551 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flynn receive payments from pharmaceutical companies?
Yes. Dr. Flynn received a total of $14,877 from 60 companies across 713 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flynn's costs compare to other urology physicians in Cincinnati?
Dr. Flynn's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flynn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cincinnati
Browse urology physicians in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology